← Leaderboards
Prakash Narayan
Angion Biomedica Corporation
$20,015,268
Attributed
$20,015,268
Total exposure
21
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$20,015,268 · 21
By mechanism
R44$17,026,807 · 10
R43$2,988,461 · 11
Top collaborators
No co-investigators on record.
Most similar at Angion Biomedica Corporation
Same institution · by research overlap
- Weizhong Cai$17,018,171
- Latha Paka$8,163,089
- Youzhi Tong$426,946
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsDoseSafetyClinical TrialsSmall MoleculeHepatocyte Growth FactorLeadBaseRattusTranslational ResearchDesignPre-ClinicalPathway InteractionsLifeMortality Vital StatisticsProteinsLaboratoriesMorbidity - Disease RateLiverPharmaceutical PreparationsInjuryAdjuvantSmall Business Innovation Research GrantUniversities
Grant awards (30)
PDGFR and KDR Inhibitors for Liver Fibrosis$769,978
R44 · FY2014 · DK · contact PI
A Novel Therapeutic for Liver Fibrosis$1,038,130
R44 · FY2013 · AA · contact PI
Antifibrotic Therapy for Chronic Kidney Disease$1,002,967
R44 · FY2013 · DK · contact PI
A Novel Therapeutic for Liver Fibrosis$971,501
R44 · FY2012 · AA · contact PI
Antifibrotic Therapy for Chronic Kidney Disease$902,494
R44 · FY2012 · DK · contact PI
An Innovative Cardioprotective$373,934
R43 · FY2012 · HL · contact PI
A Novel Therapeutic for Liver Fibrosis$269,158
R43 · FY2011 · AA · contact PI
Small Molecule Therapeutics for Renal Disease$1,094,052
R44 · FY2010 · DK · contact PI
A Novel Therapeutic for Chronic Kidney Disease$391,296
R43 · FY2010 · DK · contact PI
Antifibrotic Therapy for Chronic Kidney Disease$271,934
R43 · FY2010 · DK · contact PI
Refanalin for lung preservation and transplantation$1,117,921
R44 · FY2009 · HL · contact PI
Small Molecule Therapeutics for Renal Disease$841,379
R44 · FY2009 · DK · contact PI
Novel Small Molecules For Acute Liver Failure$181,726
R44 · FY2009 · AA · contact PI
Novel Small Molecules For Acute Liver Failure$1,079,261
R44 · FY2008 · AA · contact PI
Novel Small Molecule Therapeutic for Spinal Cord Injury$879,842
R44 · FY2008 · NS · contact PI
Novel Small Molecule Adjuvants to Drug-eluting Stents$295,467
R43 · FY2008 · HL · contact PI
Novel Small Molecule Therapeutic for Spinal Cord Injury$942,288
R44 · FY2007 · NS · contact PI
Novel Small Molecules For Acute Liver Failure$900,132
R44 · FY2007 · AA · contact PI
Small Molecule Therapeutics for Myocardial Ischemia$718,826
R44 · FY2007 · HL · contact PI
Small Molecule Therapeutics for Renal Disease$264,578
R43 · FY2007 · DK · contact PI
Novel Small Molecules For Acute Liver Failure$254,257
R43 · FY2007 · AA · contact PI
Kidney Preservation for Transplantation$913,573
R44 · FY2006 · DK · contact PI
Small Molecule Therapeutics for Myocardial Ischemia$844,903
R44 · FY2006 · HL · contact PI
Small Molecule Therapeutics for Myocardial Ischemia$225,829
R43 · FY2005 · HL
Kidney Preservation for Transplantation$127,568
R43 · FY2005 · DK
Renal Injury Prevention by SF/HGF-like Small Molecules$996,110
R44 · FY2004 · DK
Protection from Stroke by SF/HGF-like Small Molecule$210,504
R43 · FY2004 · NS
Kidney Preservation for Transplantation$112,227
R43 · FY2004 · DK
Renal Injury Prevention by SF/HGF-like Small Molecules$1,831,724
R44 · FY2003 · DK
Anti-apoptotic Mechanism of SF/HGF Mimetics$191,709
R43 · FY2003 · AA